These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2702049)

  • 1. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1989 Dec; 1(4):479-84. PubMed ID: 2702049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systemic sclerosis: from physiopathology to treatment].
    Mouthon L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S266-72. PubMed ID: 17950498
    [No Abstract]   [Full Text] [Related]  

  • 3. The microvascular endothelium in scleroderma.
    Kahaleh B
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1990 Dec; 2(6):922-8. PubMed ID: 2083158
    [No Abstract]   [Full Text] [Related]  

  • 5. Is antiendothelial cell antibody the murder weapon in systemic sclerosis?
    Youinou P; Revelen R; Bordron A
    Clin Exp Rheumatol; 1999; 17(1):35-6. PubMed ID: 10084025
    [No Abstract]   [Full Text] [Related]  

  • 6. The Second International Workshop on Scleroderma Research.
    Korn JH; Black C
    Matrix; 1993 Sep; 13(5):427-9. PubMed ID: 8246838
    [No Abstract]   [Full Text] [Related]  

  • 7. Are endothelial cells stimulated by autoantibodies in scleroderma?
    Nunzi E; Rebora A
    Acta Derm Venereol; 1983; 63(5):458-9. PubMed ID: 6197854
    [No Abstract]   [Full Text] [Related]  

  • 8. The pathophysiology of scleroderma.
    Fleischmajer R
    Int J Dermatol; 1977 Jun; 16(5):310-8. PubMed ID: 326693
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis.
    Hua-Huy T; Dinh-Xuan AT
    Pathol Biol (Paris); 2015 Apr; 63(2):61-8. PubMed ID: 25818311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in research into systemic sclerosis.
    Kahaleh B
    Lancet; 2004 Aug 14-20; 364(9434):561-2. PubMed ID: 15313340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor necrosis factor alpha in systemic scleroderma].
    Alekperov RT; Timchenko AV; Nasonov EL
    Klin Med (Mosk); 2003; 81(12):4-7. PubMed ID: 14971148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular endothelium in scleroderma.
    Kahaleh MB
    Int Rev Immunol; 1995; 12(2-4):227-45. PubMed ID: 7650422
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic sclerosis (scleroderma). Introduction.
    Black CM
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):837-8. PubMed ID: 1750794
    [No Abstract]   [Full Text] [Related]  

  • 14. The endothelium: its role in scleroderma.
    Pearson JD
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):866-71. PubMed ID: 1750799
    [No Abstract]   [Full Text] [Related]  

  • 15. Do infections facilitate the emergence of systemic sclerosis?
    Grossman C; Dovrish Z; Shoenfeld Y; Amital H
    Autoimmun Rev; 2011 Mar; 10(5):244-7. PubMed ID: 20863912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte interactions with the vascular endothelium in systemic sclerosis.
    Kahaleh B
    Clin Dermatol; 1994; 12(3):361-7. PubMed ID: 7954194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathology of scleroderma].
    Fleischmajer R; Perlish JS; Maquart FX; Kalis B
    Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
    Furst DE
    J Mal Vasc; 1999 May; 24(2):95-8. PubMed ID: 10399641
    [No Abstract]   [Full Text] [Related]  

  • 19. When connective tissues lay it on a bit too thick: systemic sclerosis, autoantibodies, and fibrous tissue proliferation.
    Luft FC
    J Mol Med (Berl); 1998 Jan; 76(1):1-2. PubMed ID: 9462861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.